\
&
Contact us
\
&
Contact us
Starts in 2 months from now
LocationBrussels Gold Hall
The European Hydrogen Week aims to put the most pressing topics of the hydrogen sector in the spotlight.
This year, the Brussels stage will be welcoming high-level speakers and experts to discuss a wide range of topics related to hydrogen. Attendees will get the chance to hear, learn and exchange with the brightest minds of the sector, with a common goal in mind: advancing this clean technology that will help Europe, and the world, achieve a carbon-neutral future.
What’s in store for the 2025 edition? Have a look at this year's programme.
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
